Document is current
Any future updates will be listed below
-
Authors
Park, Young-Shil https://orcid.org/0000-0002-6643-4245
Yoo, Ki-Young https://orcid.org/0000-0003-1470-3519
Park, Sang Kyu https://orcid.org/0000-0003-2458-981X
Hwang, Taiju https://orcid.org/0000-0002-1752-1967
Jung, Aeran https://orcid.org/0009-0003-4723-5253
Choi, Eun Jin https://orcid.org/0000-0001-7116-8538
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals Korea Co., Ltd.
- License Information
-
More Information
Article History
Received: 26 March 2024
Accepted: 21 June 2024
First Online: 28 August 2024
Declarations
:
: Choi EJ, Hwang TJ, Park SK and Yoo KY have no conflicts of interest to disclose.Park YS received research support from BioMarin, Chugai, CSL, Novo, Pfizer, Sanofi, and Takeda.Jung AR is an employee of Takeda Pharmaceuticals Korea Co., Ltd.
